Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04339621 · ClinicalTrials.gov registry record
AIH Risk Stratification With Multiparametric MRI
A clinical trial, sponsored by Perspectum.
- Terminated
- Registry status
- 11
- Enrollment target
NCT04339621: Clinical Trial study, sponsored by Perspectum.
NCT04339621 is a clinical trial that was terminated before completion, run by Perspectum. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04339621 was terminated before completion, sponsored by Perspectum.
- TERMINATED
- Registry status
- 11 participants
- Enrollment target
Study Summary
The primary aim of this study is to investigate whether the baseline cT1 can predict those whose condition relapses following treatment withdrawal. The secondary aim is to investigate correlation of cT1 with histology to explore utility as a monitoring tool. A total of 97 patients with AIH will be recruited and divided into 2 arms. 20 of which will be treatment naive and the other 77 will have been on treatment for the past 18-24 months and will be coming in for therapy cessation review.
Primary Outcome
Performance of cT1, as assessed by Area Under the Receiver Operating Curve, for predicting those patients likely to relapse following treatment cessation.
Interventions
- DEVICE LiverMultiscan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2020-10-20 |
| Est. Completion | 2023-04-15 |
Why NCT04339621 stopped before completion
NCT04339621 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which LiverMultiscan is the first listed.
NCT04339621 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04339621 about?
NCT04339621 is a clinical study titled "AIH Risk Stratification With Multiparametric MRI". The primary aim of this study is to investigate whether the baseline cT1 can predict those whose condition relapses following treatment withdrawal. The secondary aim is to investigate correlation of cT1 with histology to explore utility as a monitoring tool. A total of 97 patients with AIH will be...
What is the current status of trial NCT04339621?
This trial is currently terminated. The enrollment target is 11 participants. The study started on 2020-10-20. Estimated completion is 2023-04-15.
What interventions are being tested in trial NCT04339621?
The interventions under investigation include: LiverMultiscan (DEVICE).
Who is sponsoring clinical trial NCT04339621?
This trial is sponsored by Perspectum, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI